![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, December 13, 2012 12:12:12 PM
"Dear Victor:
In Dec. 2012, Amarantus Biosciences Inc (AMBS) declared a 1 for 1 CUSIP and name change on their outstanding shares. This was a mandatory corporate action that affected all shareholders.
A CUSIP is an identification number assigned to all stocks and registered bonds. The Committee on Uniform Securities Identification Procedures (CUSIP) oversees the entire CUSIP system. This system is used in the U.S. and Canada. Foreign securities have a similar number called the "CINS number". The new CUSIP will be 02300T109.
Although the company name and trading symbol will remain the same, this involves actually exchanging the old AMBS shares for new ones.
At this time we do not have an anticipated delivery date for the new shares. Scottrade will not post the new shares until we actually receive them from the company or their agent. Your patience is greatly appreciated.
Please let us know if you have any further questions and thank you for choosing Scottrade."
I would hate to be NSS when the CUSIP change is announced as completed and the cover begins, en masse.
Very, very long AMBS
"Out of adversity comes opportunity." Ben Franklin
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM